Julia A. Haller - 11 Aug 2022 Form 3 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Director
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol
OTLK
Transactions as of
11 Aug 2022
Net transactions value
$0
Form type
3
Filing time
15 Aug 2022, 17:14:21 UTC
Previous filing
05 Jul 2022
Next filing
04 Oct 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned